EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Clonal hematopoiesis and hematological malignancy

William G Dunn, Matthew A McLoughlin, George S Vassiliou

Journal of Clinical Investigation · 2024

DOI: 10.1172/jci180065 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Investigation, 2024. Verfasst von William G Dunn und 2 weiteren Autor:innen. Beteiligte Einrichtung: Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom. Hauptthemen laut MEDLINE: Clonal Hematopoiesis, Mutation, Hematologic Neoplasms. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 161 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Medical Research Council, Cancer Research UK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clonal hematopoiesis (CH), the expansion of hematopoietic stem cells and their progeny driven by somatic mutations in leukemia-associated genes, is a common phenomenon that rises in prevalence with advancing age to affect most people older than 70 years. CH remains subclinical in most carriers, but, in a minority, it progresses to a myeloid neoplasm, such as acute myeloid leukemia, myelodysplastic syndrome, or myeloproliferative neoplasm. Over the last decade, advances in our understanding of CH, its molecular landscape, and the risks associated with different driver gene mutations have culminated in recent developments that allow for a more precise estimation of myeloid neoplasia risk in CH carriers. In turn, this is leading to the development of translational and clinical programs to intercept and prevent CH from developing into myeloid neoplasia. Here, we give an overview of the spectrum of CH driver mutations, what is known about their pathophysiology, and how this informs the risk of incident myeloid malignancy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clonal HematopoiesisMutationHematologic NeoplasmsHumansLeukemia, Myeloid, AcuteMyeloproliferative DisordersMyelodysplastic Syndromes

Autor:innen und Institutionen

  • Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.
  • Department of Haematology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Trust, Cambridge, United Kingdom.

Förderung

  • Wellcome Trust
  • Medical Research Council
  • Cancer Research UK

Zitieren

APA

Dunn, W. G., McLoughlin, M. A., & Vassiliou, G. S. (2024). Clonal hematopoiesis and hematological malignancy. Journal of Clinical Investigation. https://doi.org/10.1172/jci180065

Vancouver

Dunn WG, McLoughlin MA, Vassiliou GS. Clonal hematopoiesis and hematological malignancy. Journal of Clinical Investigation. 2024. doi:10.1172/jci180065

BibTeX
@article{Dunn2024,
  author = {Dunn, William G and McLoughlin, Matthew A and Vassiliou, George S},
  title = {Clonal hematopoiesis and hematological malignancy},
  journal = {Journal of Clinical Investigation},
  year = {2024},
  doi = {10.1172/jci180065}
}
Kostenlos starten →